The ECOVITA Study - Validation of LUS Score in SARS-CoV-2 Disease, i.e COVID-19
ECOVITA
ECOVITA Study. Observational Study on Sars-COV 2 Population Hospitalized in the Italian Country
1 other identifier
observational
950
1 country
1
Brief Summary
Lung Ultrasound (LUS) has been revealing an extremely useful tool to identify and monitor complications from Sars-COV-2 disease. Recently, a research group has proposed a score, named LUS Score, able to optimize the use of this diagnostic technique. LUS Score is computed analyzing chest posterior and lateral spaces, considering the number of artefacts generated by the inflammed interstitium (B lines), the characteristics of the pleural line and the presence or not of consolidation areas. The comparison between LUS and chest tomography (CT), the current gold standard for the diagnosis of interstitial pneumonia by COVID-19, has confirmed from the preliminary data, the reliability of such technique. Hence, the validation on a really large sample size of the ultrasound tool performed by dedicated personnel with high expertise, may allow the validation both in the clinical practice and in emergency and ordinary wards.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 18, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 24, 2021
CompletedFirst Submitted
Initial submission to the registry
April 27, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
May 3, 2021
CompletedFirst Posted
Study publicly available on registry
May 4, 2021
CompletedMay 4, 2021
May 1, 2021
6 months
April 27, 2021
May 1, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
validation of lung ultrasound score
validation of lung ultrasound in the clinical practice of diagnosis of complications of low respiratory tracts during COVID-19
6 months
Secondary Outcomes (3)
Association of LUS score with clinical outcome
6 months
Association of LUS score with duration of hospitalization (days)
6 months
Association of LUS score with respiratory support required
6 months
Study Arms (9)
Covid Center UOC Vanvitelli, Naples
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Cotugno Hospital, Naples
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center "Del Mare Hospital", Naples
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Santa Maria delle Grazie Hospital, Pozzuoli
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Monaldi Hospital, Naples
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Vannini Hospital, Rome
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Bassini Hospital, ASST Milano Nord
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Melfi Hospital
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Covid Center Messina University Hospital
Patients hospitalized due to Sars-Cov-2 disease either in emergency or ordinary medicine/intensive care units
Interventions
the patients underwent to a non invasive diagnostic exam to identify and monitor clinical conditions and onset of respiratory complications due to COVID-19
Eligibility Criteria
patients hospitalized due to COVID19 infection
You may qualify if:
- men and women;
- confirmed COVID19 diagnosis after nasal-oropharyngeal swab;
- any symptom at hospitalization
- any therapy
- any pre-existing comorbidity
You may not qualify if:
- pregnant women
- healthy subjects with other respiratory diseases different from COVID-19
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Campania Luigi Vanvitelli
Naples, Campania, 80138, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
April 27, 2021
First Posted
May 4, 2021
Study Start
October 18, 2020
Primary Completion
April 24, 2021
Study Completion
May 3, 2021
Last Updated
May 4, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share